How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health

Yahoo Finance2024-11-19

President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the nation’s top health agency sent healthcare stocks sliding last week. Vaccine makers like Moderna (MRNA) were down more ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484602184?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/j5WYvXzNRFlXad3bTa7TtQ--~B/aD0yNDI5O3c9MzYzNDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/693db1d0-a5d6-11ef-bdb5-d669618dab8f","is_english":true,"pubTime":"2024-11-19 02:27","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2484602184","market":"us","top_or_hot":-1,"title":"How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health","media":"Yahoo Finance","content":"<div>\n<p>President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the nation’s top health agency sent healthcare stocks sliding last week. \nVaccine makers like Moderna (MRNA) were down more ...</p>\n\n<a href=\"https://finance.yahoo.com/news/how-robert-f-kennedy-jr-could-impact-the-healthcare-sector-as-secretary-of-health-182748442.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-19 02:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/how-robert-f-kennedy-jr-could-impact-the-healthcare-sector-as-secretary-of-health-182748442.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the nation’s top health agency sent healthcare stocks sliding last week. \nVaccine makers like Moderna (MRNA) were down more ...</p>\n\n<a href=\"https://finance.yahoo.com/news/how-robert-f-kennedy-jr-could-impact-the-healthcare-sector-as-secretary-of-health-182748442.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1732800096.USD","symbol_name":"摩根大通环球收益基金A (irc)","start_time":0,"source_url":"https://finance.yahoo.com/news/how-robert-f-kennedy-jr-could-impact-the-healthcare-sector-as-secretary-of-health-182748442.html","article_id":"2484602184","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/j5WYvXzNRFlXad3bTa7TtQ--~B/aD0yNDI5O3c9MzYzNDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/693db1d0-a5d6-11ef-bdb5-d669618dab8f"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484602184","pubTimestamp":1731954468,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the nation’s top health agency sent healthcare stocks sliding last week.Vaccine makers like Moderna  were down more than 5%, while larger companies like Pfizer PFE  were down about 2%. Some Wall Street analysts said the slide was an overreaction and that it's too early to tell if or how much Kennedy could impact the healthcare sector since little is known about the controversial pick's actual policies and he has yet to be confirmed by the US Senate.If confirmed as secretary of Health and Human Services, Kennedy would oversee the US Food and Drug Administration  and Centers for Disease Control and Prevention  and the head of the Centers for Medicare and Medicaid Services .GLP-1s: RFK has said he doesn’t believe the weekly injectables are the solution to the country’s obesity problem. It is unclear if he could derail current efforts by GLP-1 makers to gain Medicare coverage, which is currently not allowed for obes","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","JNJ":"强生","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","SG9999002232.USD":"Allianz Global High Payout USD","PFE":"辉瑞","CDC":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","CMS":"CMS能源","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU1196500208.SGD":"NORDEA STABLE RETURN \"HB\" (SGDHDG) ACC","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","IE00B42XCP33.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU0203201768.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"AX\" (USD) INC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","SG9999014906.USD":"大华全球优质成长基金Acc USD","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","MRNA":"Moderna, Inc.","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","NVO":"诺和诺德","BK4208":"复合型公用事业","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LLY":"礼来","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU0385154629.USD":"贝莱德营养科学基金A2"},"translate_title":"小罗伯特·F·肯尼迪作为卫生部长如何影响医疗保健行业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDC":1,"LLY":1,"MRNA":1,"NVO":1,"PFE":1,"CMS":1,"JNJ":0.9},"content_text":"President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to lead the nation’s top health agency sent healthcare stocks sliding last week. \nVaccine makers like Moderna (MRNA) were down more than 5%, while larger companies like Pfizer PFE (PFE) were down about 2%. Some Wall Street analysts said the slide was an overreaction and that it's too early to tell if or how much Kennedy could impact the healthcare sector since little is known about the controversial pick's actual policies and he has yet to be confirmed by the US Senate.\nIf confirmed as secretary of Health and Human Services, Kennedy would oversee the US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) and the head of the Centers for Medicare and Medicaid Services (CMS). \nJPMorgan healthcare analyst Chris Schott said in a note to clients that the sector is facing “a period of max uncertainty” until the Cabinet position is filled and more is known about Kennedy. But, Schott added, it also means that the large-cap stocks, as a whole, are currently trading at a 35% discount to the S&P 500, leaving room for future upside rather than more downside trading.\nMizuho’s healthcare sector expert Jared Holz said in a note to clients that he agrees with some of the big-picture issues Kennedy has identified, such as America's obesity epidemic and the dangers of ultra-processed foods.\n“The country should be much healthier than it is and there is a ton of room for improvement, including nutrition, food production, consumption, etc. This is a very complicated topic and always has been,” Holz said.\nHere's some of what we do know about Kennedy's views on major healthcare topics.\n\nVaccines: Known as an anti-vaxxer, Kennedy has questioned the need to vaccinate children and refused to get a COVID-19 vaccine, concerning some Wall Street analysts about his possible effect on the vaccine industry and how he could influence the childhood vaccine schedule, as well as the regulatory process to test and approve vaccines and other treatments. There is also speculation he and Trump’s government efficiency appointees, Elon Musk and Vivek Ramaswamy, could gut the FDA. Vaccine stocks were hurt the most on the news of Kennedy's nomination, despite him previously saying he wasn’t “taking away” anybody’s vaccines.\n\n\n\n\n  Former Republican presidential candidate Robert F. Kennedy Jr. speaks during the finale of the Tucker Carlson Live Tour at Desert Diamond Arena in Glendale, Ariz., on Oct. 31, 2024. (PATRICK T. FALLON/AFP via Getty Images)\n \n\n  PATRICK T. FALLON via Getty Images\n \n\n\nGLP-1s: RFK has said he doesn’t believe the weekly injectables are the solution to the country’s obesity problem. It is unclear if he could derail current efforts by GLP-1 makers to gain Medicare coverage, which is currently not allowed for obesity. Companies are studying the drugs' impacts on obesity-related diseases such as heart disease and sleep apnea, which are covered by Medicare and would therefore open up federal dollars for purchase. A recent report showed Medicaid, which would also be under Kennedy's purview, has contributed significantly to sales of the injectables compared to employer-sponsored and commercial insurance plans. Some analysts fear Kennedy's positions could limit access to the drugs and levels of coverage, potentially impacting the fortunes of market leaders Eli Lilly (LLY) and Novo Nordisk (NVO). Holz, however, said he “still believes GLP-1s will be the largest therapeutic category by a wide margin despite some comments from RFK noting that Americans should use other non-drug methods in order to lose weight.”\nDrug pricing: With oversight of the Centers for Medicare and Medicaid Services, Kennedy would have a chance to negotiate more or less aggressively with pharmaceutical companies than the Biden administration. That is, of course, if the Trump administration chooses to continue exercising the new powers established by the Inflation Reduction Act (IRA). \"President Trump will still be focused on this issue and could seek to 'get a better deal' via IRA negotiations than the Biden administration,\" Leerink Partners said in a note.\nFood regulations: Kennedy has been vocal about prioritizing the regulation of ultra-processed foods. Studies show these foods are contributing to obesity in the country. It's a policy the current FDA commissioner, Robert Califf, has already spoken about, and the agency has been looking to issue new rules on labeling, as well as better research on the impacts of these foods. While of more concern to food stocks than healthcare, the issue is related to his stance on obesity and GLP-1s. It is unclear how Kennedy would tackle this issue.\n\nAnjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee on most social media platforms @AnjKhem.\nClick here for in-depth analysis of the latest health industry news and events impacting stock prices","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484602184"}